Expression of the hMICL in acute myeloid leukemia—a highly reliable disease marker at diagnosis and during follow‐up

Abstract

These data identify hMICL as a myeloid leukemia-associated antigen and establishes its applicability for diagnosis and follow-up of AML patients in a standard FCM setting.